235 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (235)
- Addiction (5)
- Allergy, Asthma, & Immunology (1)
- Autoimmune Disorders (3)
- Bone & Muscle (2)
- Cancer (12)
- COVID-19 (Coronavirus) (8)
- Diabetes (6)
- Ear, Nose and Throat (7)
- Endocrine & Metabolic Disease (2)
- Gastrointestinal and Digestive Diseases (3)
- Hair and Skin Disorders (2)
- Healthy Volunteers (44)
- Heart Disease (20)
- Infectious Disease (11)
- Liver Disease (13)
- Lung Disease (2)
- Neurological Disorders (31)
- Nutrition (1)
- Obesity (9)
- Obstetrics & Gynecology (10)
- Pediatrics (17)
- Psychiatric Disorders (9)
- Rehabilitation (2)
- Stroke (2)
- Transplant (12)
- Vascular Conditions (1)
Displaying 1 - 1 of 1
Condition: Neurological Disorders / Neuropathy
Investigator: Thomas Brannagan, MD
Status: Currently Recruiting
This is a global, multicenter, placebo-controlled, phase 3 study evaluating the efficacy and safety of riliprubart in adult participants with CIDP who are refractory or had an insufficient response to standard of care (SOC) therapies, defined as Ig administered IV (IVIg) or SC (SCIg), or corticosteroids. Treatment duration will be 48 weeks. Participant must…